1. Home
  2. BHVN vs BATRA Comparison

BHVN vs BATRA Comparison

Compare BHVN & BATRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BHVN
  • BATRA
  • Stock Information
  • Founded
  • BHVN 2013
  • BATRA 1991
  • Country
  • BHVN United States
  • BATRA United States
  • Employees
  • BHVN N/A
  • BATRA N/A
  • Industry
  • BHVN Biotechnology: Pharmaceutical Preparations
  • BATRA Broadcasting
  • Sector
  • BHVN Health Care
  • BATRA Industrials
  • Exchange
  • BHVN Nasdaq
  • BATRA Nasdaq
  • Market Cap
  • BHVN 1.9B
  • BATRA 2.6B
  • IPO Year
  • BHVN 2017
  • BATRA N/A
  • Fundamental
  • Price
  • BHVN $20.25
  • BATRA $43.81
  • Analyst Decision
  • BHVN Strong Buy
  • BATRA Strong Buy
  • Analyst Count
  • BHVN 14
  • BATRA 2
  • Target Price
  • BHVN $62.92
  • BATRA $56.50
  • AVG Volume (30 Days)
  • BHVN 2.2M
  • BATRA 51.5K
  • Earning Date
  • BHVN 05-16-2025
  • BATRA 05-12-2025
  • Dividend Yield
  • BHVN N/A
  • BATRA N/A
  • EPS Growth
  • BHVN N/A
  • BATRA N/A
  • EPS
  • BHVN N/A
  • BATRA N/A
  • Revenue
  • BHVN N/A
  • BATRA $662,748,000.00
  • Revenue This Year
  • BHVN N/A
  • BATRA $7.24
  • Revenue Next Year
  • BHVN $65.26
  • BATRA $5.65
  • P/E Ratio
  • BHVN N/A
  • BATRA N/A
  • Revenue Growth
  • BHVN N/A
  • BATRA 3.45
  • 52 Week Low
  • BHVN $15.79
  • BATRA $38.67
  • 52 Week High
  • BHVN $55.70
  • BATRA $46.65
  • Technical
  • Relative Strength Index (RSI)
  • BHVN 43.84
  • BATRA 57.45
  • Support Level
  • BHVN $18.99
  • BATRA $42.88
  • Resistance Level
  • BHVN $24.06
  • BATRA $43.87
  • Average True Range (ATR)
  • BHVN 2.03
  • BATRA 0.77
  • MACD
  • BHVN 0.24
  • BATRA 0.10
  • Stochastic Oscillator
  • BHVN 42.62
  • BATRA 86.44

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.

About BATRA Atlanta Braves Holdings Inc. Series A

Atlanta Braves Holdings Inc is a holding company. It operates through its wholly-owned subsidiary, which is the owner and operator of the Atlanta Braves Major League Baseball Club and the mixed-use real estate development, The Battery Atlanta, and is the operator of the Atlanta Braves Major League Baseball Club's stadium, Truist Park. The company predominantly derives revenue related to the Braves baseball franchise and Truist Park from ticket sales, concessions, local broadcasting rights, advertising sponsorships, suites and premium seat fees, retail and licensing revenue, shared MLB revenue streams, including national broadcasting rights and licensing, and other sources. The company's reportable segments include: Baseball which generates key revenue, and Mixed-Use Development.

Share on Social Networks: